Barrett’s esophagus patient’s risk for developing esophageal cancer has been shown to be reduced by aspirin and esomeprazole combination, according to results of a phase III ASPECT trial.
https://www.worldhealth.net/news/reducing-risks-esophageal-cancer/
Reducing Risks For Esophageal Cancer